Oxford Biomedica plc (OXB) Q2 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Oxford Biomedica Plc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.642 And good morning to those on the other side of the ocean. 00:00:03.642 -- 00:00:06.872 Thank you for attending today's 00:00:06.872 -- 00:00:12.208 analyst briefing on our interim results for the six months ended 00:00:12.208 -- 00:00:15.202 June 30, 2024. 00:00:15.202 -- 00:00:20.651 It's always my pleasure to speak to you today for my fourth set of OXP 00:00:20.651 -- 00:00:25.739 results. It's also a great pleasure to see so many known 00:00:25.739 -- 00:00:30.507 faces, familiar faces here in the room. Thank you for joining us. 00:00:30.507 -- 00:00:35.618 With me today, and I'm proud to say, our newly appointed chief 00:00:35.618 -- 00:00:40.729 financial officer, Lucy Crabtree, who many of you already 00:00:40.729 -- 00:00:45.920 know probably from the past and who joined us just three 00:00:45.920 -- 00:00:49.289 weeks ago, exactly three weeks ago, Lucy. 00:00:49.289 -- 00:00:53.738 We are very excited to have you on board, Lucy, and 00:00:53.738 -- 00:00:58.949 as we embark on a very new or next chapter, let's say, of our journey. 00:00:58.949 -- 00:01:04.019 And I will let Lucy introduce herself when we start her part in the presentation 00:01:04.019 -- 00:01:05.422 shortly. 00:01:05.422 -- 00:01:10.397 I'm also delighted to have our Chief Business Officer, Dr. 00:01:10.397 -- 00:01:15.472 Sébastien Riboud, with us, whom you already know from the past. 00:01:15.472 -- 00:01:20.677 You will hear from both of them in due course throughout this presentation. 00:01:20.677 -- 00:01:27.327 Also with us in the room is Stuart Painter, our former CFO 00:01:27.371 -- 00:01:32.441 for the Q&A section, eventually. And he 00:01:32.441 -- 00:01:37.768 has recently, as you know, handed over the reins to you, Lucy. 00:01:39.796 -- 00:01:4...